Jobs
View more job listings or post a job
Pliant Therapeutics This highly visible leadership role thrives through fierce collaboration with multidisciplinary teams, embracing broad experience in modern DMPK science to optimize and advance both small and large molecule candidates.  
Vir Biotechnology Senior Scientist I, Computational Chemistry
Vir Biotechnology Scientist II, Assay Automation & Compound Screening
FibroGen Senior Director Clinical Pharmacology
University of California, Davis TOXICOLOGY GROUP LEADER (LABORATORY RESCHEARCH SUPERVISOR 2)                    
Xencor Scientist, Immuno-Oncology
Xencor Research Associate 3, Immuno-Oncology
Genentech Senior Scientist, Small Molecule Analytical Chemistry
Roivant Sciences Director, Translational Sciences and Immunology
Horizon Therapeutics Senior Clinical Pharmacologist
Post a job
Symposium

[Free Online Symposium] Promising Biotech Startups: Their Science and Stories


Speakers: Darren Cooke, Life Sciences Entrepreneurship Center, UC Berkeley; Sam Lai, Inhalon; Sigi Neerken, InnoSIGN; Scott Shively, Bexion; Angela Lai, Betteromics; Robert Li, LTZ Therapeutics; Matthew O'Connor, Cyclarity; Cindy McReynolds, EicOsis
Organizers: Toby Freedman PhD, Synapsis Search Recruiting; Shichang Miao PhD, Amgen; Donald McCarthy PhD, Samsara BioCapital; Elina Lavit, OncoNano Medicine Inc.
Date: 2023-02-06
Time: 8:30-13:30 Pacific Time
Registration fee: 0
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2023-02-03  (it will close sooner if the seating cap is reached)

About the Topic

Note: This is an online meeting, The Zoom link will be sent to the registrants 1+ days before the event.


About the Speakers

PST

EST

Topic

Presenter

8:30-8:40 am

11:30-11:40 am

Welcome Remarks

Shichang Miao

8:40-9:15 am

11:40-12:15 pm

InnoSIGN: Revolutionize precision medicine through OncoSIGNal pathway activity profiling

Sigi Neerken, PhD, Co-founder and Chief Business Officer, InnoSIGN

9:15-9:50 am

12:15-12:50 pm

The role of angel investors and startup accelerators in the life sciences startup and fundraising ecosystem

Darren Cooke, JD. Executive Director, Life Sciences Entrepreneurship Center, UC Berkeley

9:50-10:25 am

12:50-1:25 pm

Bexion Pharmaceuticals: Leveraging biologic immunotherapy to treat solid tumor cancers

Scott Shively, CEO & President, BexionPharmaceuticals, Inc.

10:25-10:35 am

1:25-1:35 pm

Break

-

10:35-11:10 am

1:35-2:10 pm

Betteromics: A data operating system for the modern life science enterprise

Angela Lai, CEO, Betteromics Inc.

11:10-11:45 am

2:10-2:45 pm

LTZ Therapeutics: Lift to Zenith with novel immunotherapies

Robert Li, PhD, Co-founder & CEO, LTZ Therapeutics

11:45-12:20 pm

2:45-3:20 pm

Cyclarity Therapeutics: Targeting oxidized cholesterol to reverse atherosclerosis: a new drug and a new paradigm

Matthew O’Connor, Ph.D., Co-CEO, CyclarityTherapeutics

12:20-12:55 pm

3:20-3:55 pm

EicOsis: From horses to humans: Identification of a novel drug target, the soluble epoxide hydrolase, for the treatment of pain and chronic inflammation

Cindy McReynolds, PhD, CEO, EicOsis

12:55-1:30 pm

3:55-4:30 pm

TBD

Sam Lai, Founder / CSO, Inhalon

1:30-2:00 pm

4:30-5:00 pm

Panel Discussion

All Speakers

Other Events of PBSS-San Francisco Bay:

2023-04-03, [Free Online Symposium] Pediatric Drug Development: Regulatory and Clinical Considerations and Clinical Pharmacology Approaches
2023-04-24, [In-Person] Preclinical Development & IND Filing for Small Molecules: Nuts, Bolts and Best Practices
2023-05-24, [In-Person] Preclinical Development and IND Filing for Antibody-Based Therapeutics: Nuts, Bolts and Best Practices
2023-05-26, [Free Online Workshop] Nonclinical Carcinogenicity Studies: Fundamentals, Case Studies and Regulatory Trends
2023-06-20, [Free Online Symposium] Highlights of 2022 FDA Approvals
©Pharmaceutical & BioScience Society, International; Last Modified: 3/20/2023; Admin Logon
 Ads (in random order)
Submit a Text Ad
($250 for 2 months)
Origin Bioanalytical Laboratory, Inc. Bioanalytical CRO specializing in LC-MS/MS method development, validation, non-GLP and GLP analysis to support PK/TK studies, with ocular expertise.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
BioTether Sciences CRO focused on bioanalysis and cell-based assays. Regulated analysis for immunogenicity and PK/PD. Gene and cell therapy product characterization.
Submit a Text Ad